Clinical trial
PPAR-gamma: a Novel Therapeutic Target in Asthma?
NCT01134835 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PPAR-gamma: a Novel Therapeutic Target in Asthma?
- Lead sponsor
- University of Nottingham
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- June 30, 2010
- Completion date
- July 31, 2012
- Enrollment
- 68 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.